Maghreb Edition

Morocco says it’s serious about Covid-19 vaccination, people still doubt itF

Posted On 3 December 2020

Number of times this article was read : 1300

Morocco hopes to launch an ambitious vaccination campaign against the novel coronavirus by year-end, but its efforts have
sparked suspicion and rumours in the country, hard-hit by the pandemic. The North African kingdom is hoping to immunise 20 million adults against the Covid-19 illness within three months, using vaccinations from China’s Sinopharm and a UK-sourced shot developed by AstraZeneca and Oxford University.

Health Minister Khalid Ait Taleb told AFP that each country was free to “decree emergency use” of the vaccine of its choice. Britain on Wednesday became the first country to approve Pfizer-BioNTech’s Covid-19 vaccine for general use, while the AstraZeneca/Oxford University shot is expected to come onstream soon.

The launch date for the campaign in Morocco “will depend on when the vaccines are certified for use but also on the delivery schedule”, Ait Taleb added. But even before the campaign began, rumours pushed by sceptics have flooded social media, including a fake “draft law” stating that vaccination would be mandatory in Morocco, forcing the health ministry to issue a denial last month. And this week, a photo of a young man being hauled away by six police officers, with the caption “official: vaccination campaign launched in Morocco”, was denounced as “fake news” by the Twitter account of the DGSN security service.

Morocco in August signed a deal to take part in clinical tests of a vaccine developed by Chinese company Sinopharm, which has agreed to provide the kingdom with 10 million doses before the end of the year if results are successful. Even as they await preliminary results of phase three tests, the Moroccan authorities are preparing a “viral retaliation”, Ait Taleb said.

‘Fanciful criticisms’

The novel coronavirus has battered Morocco, where daily detected cases are running at above 5,000 per day and recorded deaths from the virus have topped 5,900, in a country of 37 million. The death rate has been relatively low at around 1.7 percent of recorded cases. But in the port city of Casablanca, the beating heart of the Moroccan economy, under-staffed  hospitals are close to bursting. Hard-stretched medical staff, on the front lines of the pandemic since March, are showing signs of exhaustion. But the government is hoping that by mobilising 12,750 medics from the public and private sectors, military doctors and the Moroccan Red Crescent, it will be able to hit its target for vaccinations.

The first jabs will be reserved for “front line” staff in the health and security services as well as people in vital sectors such as transportation, and at-risk groups including over-65s and those with chronic conditions, the health minister said. But as the government steps up preparations for the campaign, public sentiment is divided between hope and anxiety. On social media, “everyone has their own information”, said news website Hesspress.

The rumours began to swirl as soon as the November 9 announcement that King Mohammed VI had given the go-ahead for a “mass immunisation operation”, without specifying the timeline or type of vaccine. Criticisms voiced online have ranged from doubts over the effectiveness of the vaccines to the fear of being “guinea-pigs” — or that the jab could modify the receiver’s DNA. Traditional media have been hosting experts every day to counter the wave of scepticism and refute what news website Media24 called “eccentric, fanciful criticisms.”

But the Economiste newspaper said news of the vaccine has blown “a gust of optimism” into an economy plunged into recession by the pandemic as well as a punishing drought that has hit the agriculture sector. In late September, Morocco’s central bank downgraded its already dire forecasts, predicting GDP would shrink by some 6.3 percent in 2020 and forecasting “a slower recovery than expected”. But for some in the vital tourism sector, facing disaster since the country closed its borders in mid-March, the vaccine finally brings hope of a relaunch.

By Sophie Pons, AFP
The North Africa Journal's WhatsApp Group
.

Most Recent Stories from the Region

Trump Sends Controversial Envoy to South Africa at a Diplomatic Low Point$

Leo Brent Bozell III has arrived in Pretoria as the new U.S. ambassador to South Africa, stepping into one of the most strained periods in bilateral relations in recent years. His appointment, amid disputes over Israel, Afrikaner rights allegations, and diplomatic expulsions, reflects a politically charged moment that could redefine the trajectory of U.S.–South Africa ties.

Morocco Detains Civic Activist Amid Online Speech Concerns$

Moroccan authorities have detained Mohammed Khalif,a Casablanca-based member of the youth movement GenZ212, following a home search and seizure of his computer. Charges have not yet been publicly disclosed. His arrest comes days after another GenZ212 member was prosecuted over alleged online incitement, raising questions about the legal climate surrounding youth activism and digital expression in Morocco.

Tunisia: Arrest of Opposition Figure Olfa Hamdi Raises Concerns$

A Tunisian civil liberties organization has called for transparency and the release of opposition party leader Olfa Hamdi following reports of her detention. With no formal statement issued by authorities several days after the alleged arrest, rights advocates say the silence raises concerns about due process and the state of political freedoms in Tunisia.

Written by The North Africa Journal

The North Africa Journal is a leading English-language publication focused on North Africa. The Journal covers primarily the Maghreb region and expands its general coverage to the Sahel, Egypt, and beyond, when events in those regions affect the broader North Africa geography. The Journal does not have any affiliation with any institution and has been independent since its founding in 1996. Our position is to always bring our best analysis of events affecting the region, and remain as neutral as humanly possible. Our coverage is not limited to one single topic, but ranges from economic and political affairs, to security, defense, social and environmental issues. We rely on our full staff analysts and editors to bring you best-in-class analysis. We also work with sister company MEA Risk LLC, to leverage the presence on the ground of a solid network of contributors and experts. Information on MEA Risk can be found at www.MEA-Risk.com.